Pacific Radiance (RXS) H1 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2023 earnings summary
5 Nov, 2026Executive summary
6M 2023 continuing revenue rose 7% YoY to US$16.3m, while gross profit fell 12% to US$5.2m; continuing profit for the period was US$3.5m, versus US$21.0m in 6M 2022.
Prior-year results included substantial one-off restructuring-related gains; 6M 2023 operating cash flow was positive at US$1.6m and cash ended the period at US$26.9m.
Financial highlights
6M continuing revenue US$16.284m, up 7% YoY; gross profit US$5.190m, down 12%; profit before tax US$3.506m and net profit US$3.464m.
2Q continuing revenue US$8.065m, down 24% YoY; gross profit US$2.095m, down 56%; profit before tax US$0.349m and net profit US$0.660m.
6M 2022 other operating income included US$22.258m debt-forgiveness gain, alongside vessel-sale and financial-guarantee release gains; these restructuring-related items did not recur in 6M 2023.
6M 2023 basic and diluted EPS were 0.8 US cents, versus 3.8 US cents total in 6M 2022, including continuing and discontinued operations.
Outlook and guidance
Offshore oil and gas activity continued improving in 2023; demand was described as supportive, with vessel supply constrained after years of tonnage removals and modest newbuilding.
Offshore wind investment tied to energy transition and energy security is expected to support demand for vessels used in wind-farm construction and maintenance; opportunities will be pursued cautiously amid geopolitical and economic uncertainty.
Latest events from Pacific Radiance
- Revenue grew, adjusted EBITDA stayed positive, and rights-issue funding backed offshore growth.RXS
H2 2023 - Debt relief drove a sharp H1 profit rise as vessel and shipyard revenue grew.RXS
H1 2024 - Revenue grew 40%, while one-time gains lifted profit and offshore-wind investment advanced.RXS
H2 2024 - Revenue and gross profit grew, but net profit fell as prior-period gains did not recur.RXS
H1 2025 - Core operations strengthened, but reported profit fell on prior-year gains and warrant remeasurement.RXS
H2 2025 - Revenue fell 19% and net profit 47% as Middle East disruption weighed on operations.RXS
H1 2026